102 related articles for article (PubMed ID: 9493980)
1. Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer.
Tortoriello A; Facchini G; Caponigro F; Santangelo M; Benassai G; Persico G; Citarella A; Carola M; Marzano N; Iaffaioli RV
Breast Cancer Res Treat; 1998 Jan; 47(1):91-7. PubMed ID: 9493980
[TBL] [Abstract][Full Text] [Related]
2. Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.
Livingston RB; Ellis GK; Gralow JR; Williams MA; White R; McGuirt C; Adamkiewicz BB; Long CA
J Clin Oncol; 1997 Apr; 15(4):1395-400. PubMed ID: 9193331
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF
Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel plus vinorelbine in metastatic breast Ca patients with contraindications to receive anthracyclines.
Martin M; Casado A; Perez Segura P; Garcia Carbonero I; Diaz-Rubio E
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):28-30. PubMed ID: 9516600
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study.
Fazeny B; Zifko U; Meryn S; Huber H; Grisold W; Dittrich C
Cancer Chemother Pharmacol; 1996; 39(1-2):150-6. PubMed ID: 8995513
[TBL] [Abstract][Full Text] [Related]
6. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of vinorelbine and paclitaxel in small-cell lung cancer.
Iaffaioli RV; Facchini G; Tortoriello A; Caponigro F; Illiano A; Gentile M; Gravina A; Muto P
Cancer Chemother Pharmacol; 1997; 41(1):86-90. PubMed ID: 9443619
[TBL] [Abstract][Full Text] [Related]
8. Vinorelbine combined with paclitaxel infused over 96 hours (VI-TA-96) for patients with metastatic breast carcinoma.
Cocconi G; Mambrini A; Quarta M; Vasini G; Bella MA; Ferrozzi F; Beretta MD
Cancer; 2000 Jun; 88(12):2731-8. PubMed ID: 10870055
[TBL] [Abstract][Full Text] [Related]
9. Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
Havlin KA; Ramirez MJ; Legler CM; Harris LN; Matulonis UA; Hohneker JA; Hayes DF; Winer EP
Cancer Chemother Pharmacol; 1999; 43(1):68-72. PubMed ID: 9923543
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
Kosmas C; Agelaki S; Giannakakis T; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
Oncology; 2002; 62(2):103-9. PubMed ID: 11914594
[TBL] [Abstract][Full Text] [Related]
11. Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study.
Terenziani M; Demicheli R; Brambilla C; Ferrari L; Moliterni A; Zambetti M; Caraceni A; Martini C; Bonadonna G
Breast Cancer Res Treat; 1996; 39(3):285-91. PubMed ID: 8877008
[TBL] [Abstract][Full Text] [Related]
12. Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study.
Polyzos A; Tsavaris N; Kosmas C; Gogas H; Toufexi H; Kosmidis C; Markopoulos C; Giannopoulos A; Papadopoulos O; Stamatiadis D; Kouraklis G
J Chemother; 2003 Dec; 15(6):607-12. PubMed ID: 14998089
[TBL] [Abstract][Full Text] [Related]
13. Weekly schedule of vinorelbine in pretreated breast cancer patients.
Nisticò C; Garufi C; Milella M; Vaccaro A; D'Ottavio AM; Fabi A; Pace A; Bove L; Tropea F; Marsella A; Izzo F; D'Attino RM; Ferraresi V; De Marco S; Terzoli E
Breast Cancer Res Treat; 2000 Feb; 59(3):223-9. PubMed ID: 10832592
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II study.
Michelotti A; Gennari A; Salvadori B; Tognoni A; Tibaldi C; Baldini E; Conte PF
Ann Oncol; 1996 Oct; 7(8):857-60. PubMed ID: 8922202
[TBL] [Abstract][Full Text] [Related]
15. Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients.
Ellis GK; Gralow JR; Pierce HI; Williams MA; Livingston RB
J Clin Oncol; 1999 May; 17(5):1407-12. PubMed ID: 10334525
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.
Ibrahim NK; Rahman Z; Valero V; Willey J; Theriault RL; Buzdar AU; Murray JL; Bast R; Hortobagyi GN
Cancer; 1999 Oct; 86(7):1251-7. PubMed ID: 10506711
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.
Ibrahim NK; Valero V; Rahman Z; Theriault RL; Walters RS; Buzdar AU; Booser DJ; Holmes FA; Murray JL; Willey J; Bast R; Hortobagyi GN
Cancer Invest; 2001; 19(5):459-66. PubMed ID: 11458813
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of paclitaxel combined with vinorelbine in patients with advanced breast cancer.
Spano JP; Bouillet T; Boaziz C; Piperno-Neumann S; Brunel P; Hennebelle F; Amsalhem P; Brunet-Pommeyrol A; Kanoui A; Morin F; Breau JL; Morere JF
Am J Clin Oncol; 2004 Jun; 27(3):317-21. PubMed ID: 15170156
[TBL] [Abstract][Full Text] [Related]
19. Combination paclitaxel and vinorelbine therapy: in vitro cytotoxic interactions and dose-escalation study in breast cancer patients previously exposed to anthracyclines.
Culine S; Roch I; Pinguet F; Romieu G; Bressolle F
Int J Oncol; 1999 May; 14(5):999-1006. PubMed ID: 10200354
[TBL] [Abstract][Full Text] [Related]
20. Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel.
Fleming GF; Waggoner SE; Rotmensch J; Langhauser C
Am J Clin Oncol; 2001 Feb; 24(1):52-7. PubMed ID: 11232950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
